Human Drugs

× UPDATE! Updated as of 11 November 2024.
 
Product Information
Registration Number
Generic Name
Brand Name
Dosage Strength
Dosage Form
Pharmacologic Category
Manufacturer
Country of Origin
Application Type
Issuance Date
Expiry Date
View DRP-7266-03 Phytomenadione Menavit-K 10 mg/mL Solution For Injection (I.V./I.M./S.C.) Vitamin Wuhu Kangqi Pharmaceutical Co., Ltd. China Automatic Renewal 23 June 2021 18 June 2025
View DRP-6136-05 Ampicillin (as sodium) Bampi-1 1 g Powder For Injection (I.M./I.V.) Antibacterial (Penicillin) North China Pharmaceutical Co., Ltd China CLIDP Conversion 06 February 2024 13 March 2029
View DRP-6136-01 Ampicillin (as sodium) Gocillin 1 g Powder For Injection (I.M./I.V.) Antibacterial (Penicillin) NORTH CHINA PHARMACEUTICAL CO., LTD. China CLIDP Conversion 16 February 2024 13 March 2029
View DRP-6180-03 Ceftazidime (as Pentahydrate) Keftam 1 g Powder for Injection (I.M./I.V.) Antibacterial (Cephalosporin) NCPC HEBEI HUAMIN PHARMACEUTICAL CO., LTD. China Automatic Renewal 07 February 2024 13 March 2029
View DRP-13179-01 Glutathione None 600 mg Lyophilized Powder for Injection (IM/IV) Antidote Reyoung Pharmaceutical Co. Ltd. China CLIDP Conversion 21 June 2023 14 November 2027
View DRP-14978 Piperacillin (as sodium) + Tazobactam (as sodium) Tazem 4 g/500 mg Powder for Injection (I.V.) Antibacterial Pharmax India Private Limited India Initial 05 March 2024 05 March 2029
View DRP-14979 Bupivacaine hydrochloride in Dextrose Masocaine Heavy 5 mg/80 mg per mL Solution for Injection (Intrathecal) Local Anesthetic Mason Pharma India Initial 05 March 2024 05 March 2029
View DRP-14977 Isoxsuprine hydrochloride. Saphrinox 5 mg/mL (10 mg/2 mL) Solution for Injection (I.M./I.V.) Peripheral Vasodilator Kilitch Drugs (India) Ltd. India Initial 05 March 2024 05 March 2029
View DR-XY49013 Cefuroxime (as axetil) Eoroxime-250 250 mg/5 mL Powder for Oral Suspension Antibacterial Zee Laboratories Limited India Initial 05 March 2024 05 March 2029
View DRP-14962 Losartan Potassium Saphlor 50 50 mg Film-Coated Tablet Angiotensin II Receptor Blocker Sapphire Lifesciences Pvt., Ltd. India Initial 05 March 2024 05 March 2029
View DRP-14961 Losartan Potassium Saphlor 100 100 mg Film-Coated Tablet Angiotensin II Receptor Blocker Sapphire Lifesciences Pvt., Ltd. India Initial 05 March 2024 05 March 2029
View DRP-14973 Ciprofloxacin (as hydrochloride) Floproxa 3 mg/mL (0.3% w/v) Sterile Solution (Drops) Antibacterial (Fluoroquinolone) Indiana Ophthalmics India Initial 05 March 2024 05 March 2029
View DRP-15006 Bupivacaine hydrochloride B-cane Heavy 5 mg/mL (0.5% w/v) Solution for Intrathecal Injection Local Anesthetic (Amide) Aculife Healthcare Private Limited India Initial 08 March 2024 08 March 2029
View DRP-14997 Irinotecan Hydrochloride Trihydrate Fin-Otecan 20 mg/mL (100 mg/5 mL) Concentrate Solution for IV Infusion Antineoplastic Venus Remedies, Limited India Initial 06 March 2024 06 March 2029
View DRP-15007 Bupivacaine hydrochloride Spentocaine Heavy 5 mg/mL (0.5% w/v) Solution for Intrathecal Injection Local Anesthetic (Amide) Steril-Gene Life Sciences (P) Limited India Initial 08 March 2024 08 March 2029
View DRP-15001 Sunitinib (as malate) Alsuni 12.5 mg Capsule Antineoplastic Agent Lotus Pharmaceutical Co., Ltd. (Nantou Plant) Taiwan Initial 07 March 2024 07 March 2029
View DRP-15000 Sunitinib (as malate) Alsuni 50 mg Capsule Antineoplastic Agent Lotus Pharmaceutical Co., Ltd. (Nantou Plant) Taiwan Initial 07 March 2024 07 March 2029
View DRP-14998 Amiodarone hydrochloride Miorad 50 mg/mL (150 mg/3 mL) Concentrate Solution for Injection (IV) Anti-arrhythmic Swiss Parenterals Ltd. (Block-B) India Initial 07 March 2024 07 March 2029
View DR-XY 49015 Bupivacaine hydrochloride Bucain Spinal Heavy 5 mg/mL (0.5% w/v) Solution for Intrathecal Injection Local Anesthetic (Amide) PT. Bernofarm Indonesia Initial 05 March 2024 08 March 2029
View DRP-15005 Bupivacaine hydrochloride Spinlok 5 mg/mL (0.5% w/v) Solution for Intrathecal Injection Local Anesthetic (Amide) Shree Anand Life Sciences, Ltd. India Initial 08 March 2024 08 March 2029